Measles virus (MV) infection and vaccination induce long-lasting immunity and neutralizing-antibody responses that are directed against the MV haemagglutinin (H) and the fusion (F) protein. A new MV genotype, D7, emerged recently in western Germany and rapidly replaced the long-term endemically circulating genotypes C2 and D6. Analysis of the H gene of C2, D6, D7 and vaccine viruses revealed uniform sequences for each genotype. Interestingly, a consistent exchange of seven distinct amino acids in the D7 H was observed when compared with residues shared between C2, D6 and vaccine viruses, and one exchange (D416→N) in the D7 H was associated with an additional N-linked glycosylation. In contrast, the F gene is highly conserved between MVs of these genotypes. To test whether the D7 H protein escapes from antibody responses that were raised against earlier circulating or vaccine viruses, the neutralizing capacity of mAbs recognizing seven distinct domains on the H of an Edmonston-related MV was compared. The mAbs revealed a selective and complete loss of two neutralizing epitopes on the D7 H when compared with C2, D6 and vaccine viruses. To assess whether these alterations of the D7 H affect the neutralizing capacity of polyclonal B-cell responses, genotype-specific antisera were produced in cotton rats. However, no significant genotype-dependent difference was found. Likewise, human sera obtained from vaccinees (n=7) and convalescents (n=6) did not distinguish between the MV genotypes. Although the hypothesis of selection of D7 viruses by pre-existing neutralizing antibodies is compatible with the differing pattern of neutralizing epitopes on the H protein, it was not confirmed by the results of MV neutralization with polyclonal sera.
CattaneoR.,
RoseJ. K.1993; Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 67:1493–1502
DamienB.,
HuissS.,
SchneiderF.,
MullerC. P.1998; Susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. J Med Virol 56:85–90[CrossRef]
DörigR. E.,
MarcilA.,
ChopraA.,
RichardsonC. D.1993; The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295–305[CrossRef]
EdmonsonM. B.,
AddissD. G.,
McPhersonJ. T.,
BergJ. L.,
CircoS. R.,
DavisJ. P.1990; Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2467–2471[CrossRef]
ErlenhöferC.,
WurzerW. J.,
LöfflerS.,
Schneider-SchauliesS.,
ter MeulenV.,
Schneider-SchauliesJ.2001; CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol 75:4499–4505[CrossRef]
ErlenhöferC.,
DuprexW. P.,
RimaB. K.,
ter MeulenV.,
Schneider-SchauliesJ.2002; Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 83:1431–1436
ErtlO. T.,
WenzD. C.,
BoucheF. B.,
BerbersG. A. M.,
MullerC. P.2003; Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response. Arch Virol 148:2195–2206[CrossRef]
FayolleJ.,
VerrierB.,
BucklandR.,
WildT. F.1999; Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization. J Virol 73:787–790
FournierP.,
AmmerlaanW.,
ZieglerD.7 other authors1996; Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. Int Immunol 8:1441–1451[CrossRef]
FournierP.,
BronsN. H. C.,
BerbersG. A. M.,
WiesmüllerK. H.,
FleckensteinB. T.,
SchneiderF.,
JungG.,
MullerC. P.1997; Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J Gen Virol 78:1295–1302
GiraudonP.,
WildT. F.1985; Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144:46–58[CrossRef]
HengelH.,
EßlingerC.,
PoolJ.,
GoulmyE.,
KoszinowskiU. H.1995; Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76:2987–2997[CrossRef]
HollandJ. J.,
de la TorreJ. C.,
SteinhauerD. A.,
ClarkeD.,
DuarteE.,
DomingoE.1989; Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions. J Virol 63:5030–5036
HuA.,
CattaneoR.,
SchwartzS.,
NorrbyE.1994; Role of N -linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol 75:1043–1052[CrossRef]
JinL.,
RichardsA.,
BrownD. W. G.1996; Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol Cell Probes 10:191–200[CrossRef]
JohnstonI. C. D.,
ter MeulenV.,
Schneider-SchauliesJ.,
Schneider-SchauliesS.1999; A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol 73:6903–6915
KlaggeI. M.,
ter MeulenV.,
Schneider-SchauliesS.2000; Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface. Eur J Immunol 30:2741–2750[CrossRef]
KlingeleM.,
HartterH. K.,
AduF.,
AmmerlaanW.,
IkusikaW.,
MullerC. P.2000; Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody. J Med Virol 62:91–98[CrossRef]
KuboH.,
IritaniN.,
SetoY.2003; Co-circulation of two genotypes of measles virus and mutual change of the prevailing genotypes every few years in Osaka, Japan. J Med Virol 69:273–278[CrossRef]
LangedijkJ. P. M.,
DausF. J.,
van OirschotJ. T.1997; Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol 71:6155–6167
NanicheD.,
Varior-KrishnanF.,
CervoniF.,
WildT. F.,
RossiB.,
Rabourdin-CombeC.,
GerlierD.1993; Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025–6032
NiewieskS.1999; Cotton rats ( Sigmodon hispidus ): an animal model to study the pathogenesis of measles virus infection. Immunol Lett 65:47–50[CrossRef]
NiewieskS.,
EisenhuthI.,
FooksA.,
CleggJ. C. S.,
SchnorrJ.-J.,
Schneider-SchauliesS.,
ter MeulenV.1997; Measles virus-induced immune suppression in the cotton rat ( Sigmodon hispidus ) model depends on viral glycoproteins. J Virol 71:7214–7219
NiewieskS.,
GötzelmannM.,
ter MeulenV.2000; Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc Natl Acad Sci U S A 97:4251–4255[CrossRef]
OhgimotoS.,
OhgimotoK.,
NiewieskS.7 other authors2001; The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro
. J Gen Virol 82:1835–1844
PedersonI. R.,
MordhorstC. H.,
GlikmannG.,
von MagnusH.1989; Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. Vaccine 7:345–348[CrossRef]
PfeufferJ.,
PüschelK.,
ter MeulenV.,
Schneider-SchauliesJ.,
NiewieskS.2003; Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model ( Sigmodon hispidus ). J Virol 77:150–158[CrossRef]
PützM. M.,
HoebekeJ.,
AmmerlaanW.,
SchneiderS.,
MullerC. P.2003; Functional fine-mapping and molecular modeling of a conserved loop epitope of the measles virus hemagglutinin protein. Eur J Biochem 270:1515–1527[CrossRef]
RotaJ. S.,
HummelK. B.,
RotaP. A.,
BelliniW. J.1992; Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188:135–142[CrossRef]
RotaJ. S.,
WangZ.-D.,
RotaP. A.,
BelliniW. J.1994; Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res 31:317–330[CrossRef]
SaitoH.,
NakagomiO.,
MoritaM.1995; Molecular identification of two distinct hemagglutinin types of measles virus by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Mol Cell Probes 9:1–8[CrossRef]
SantibanezS.,
HeiderA.,
GerikeE.,
AgafonovA.,
SchreierE.1999; Genotyping of measles virus isolates from Central Europe and Russia. J Med Virol 58:313–320[CrossRef]
SchragS. J.,
RotaP. A.,
BelliniW. J.1999; Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol 73:51–54
SchulzeI. T.1997; Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis 176 (Suppl. 1):S24–S28[CrossRef]
SinitsynaO. A.,
KhudaverdyanO. E.,
SteinbergL. L.,
NagievaF. G.,
LotteV. D.,
DorofeevaL. V.,
RozinaE. E.,
BoriskinYu. S.1990; Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo
. Res Virol 141:517–531[CrossRef]
SkehelJ. J.,
StevensD. J.,
DanielsR. S.,
DouglasA. R.,
KnossowM.,
WilsonI. A.,
WileyD. C.1984; A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81:1779–1783[CrossRef]
SternL. B.-L.,
GreenbergM.,
GershoniJ. M.,
RozenblattS.1995; The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol 69:1661–1668
TischerA.,
SantibanezS.,
SiedlerA.,
HeiderA.,
HengelH.2004; Laboratory investigations are indispensable to monitor the progress of measles elimination – results of the German Measles Sentinel 1999–2003. J Clin Virol 31:165–178[CrossRef]
van BinnendijkR. S.,
van den HofS.,
van den KerkhofH.,
KohlR. H. G.,
WooninkF.,
BerbersG. A. M.,
Conyn-van SpaendonckM. A. E.,
KimmanT. G.2003; Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in the Netherlands. J Infect Dis 188:898–903[CrossRef]
VarsanyiT. M.,
MoreinB.,
LöveA.,
NorrbyE.1987; Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol 61:3896–3901
VongpunsawadS.,
OezgunN.,
BraunW.,
CattaneoR.2004; Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78:302–313[CrossRef]
WHO2003; Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemiol Rec 78:229–232
WildT. F.,
MalvoisinE.,
BucklandR.1991; Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 72:439–442[CrossRef]
ZieglerD.,
FournierP.,
BerbersG. A. H.7 other authors1996; Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. J Gen Virol 77:2479–2489[CrossRef]